The advertisement promotes Cosentyx, highlighting its unique approval as an IL-17 antagonist with two maintenance dosing options, while also providing important safety information and contraindications.
Creative Information
| CID: | d699f754-b0f3-419e-89a3-04690f6ec3f7 |
| CRID: | 82_5530-801211 |
| Domain: | cosentyx.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $0.10 |
| Timestamp: | 10/31/2025, 1:29:15 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 2:46:01 AM | 5.04s | |
| adomain_analysis | success | 10/31/2025, 5:25:33 AM | 4.09s | |
| adomain_capture | success | 10/31/2025, 5:25:29 AM | 0.15s | |
| ad_render | success | 10/31/2025, 2:45:56 AM | 26.42s | |
| brand_mapping | success | 10/31/2025, 5:25:31 AM | 1.69s | |
Analysis Results
Ad Format: banner
Brands: Cosentyx
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1045.59 KB | ||||||||||||||||||||||
| Render Time: | 10.44 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1077.51 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

